Уважаемые пользователи!
Мы рады представить вам новую версию сайта с улучшенным интерфейсом и новыми возможностями.
Приглашаем вас ознакомиться и поделиться обратной связью. Спасибо, что вы с нами!
Попробовать!
RUEN

Diabetes as Risk Factor for Incident Coronary Heart Disease in Women Compared With Men: A Systematic Review and Meta-Analysis of 64 Cohorts Including 858,507 Individuals and 28,203 Coronary Events

02.06.20141953
This meta-analysis used PubMed to identify prospective population-based cohort studies published between January 1, 1966 and February 13, 2013.

Vitamin, Mineral, and Multivitamin Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: U.S. Preventive Services Task Force Recommendation Statement

30.05.20141753
What are the updates from the 2003 U.S. Preventive Services Task Force (USPSTF) recommendations on vitamin supplements to prevent cardiovascular disease and cancer?

More Brain Bleeds With Stroke Drug in 'Real World'

29.05.20141616
In a real-world practice setting, the use of tissue plasminogen activator (tPA, Alteplase) results in a higher rate of intracerebral hemorrhage than was seen in the well-controlled clinical trials that led to widespread use of the treatment in stroke patients, researchers said here.

Temporal Trends in the Use of High-Dose Potent Statins following Acute Coronary Syndrome in Israel

28.05.20142329
This study aimed to evaluate factors associated with the prescription of high-dose potent statin (HDPS) therapy following hospitalization for acute coronary events.

The risk of atrial fibrillation in patients with rheumatoid arthritis

27.05.20141742
Prior research suggests an important role of systemic inflammation in pathogenesis of atrial fibrillation (AF).

SYMPLICITY HTN-3 Results Suggest No Benefit of Renal Artery Denervation on Ambulatory Blood Pressure

26.05.20141688
There was no demonstrated benefit of renal artery denervation on reduction in ambulatory blood pressure over 24-hours or over day and night periods compared with sham.

Outcomes in Atrial Fibrillation Patients With and Without Ventricular Hypertrophy When Treated With a Lenient Rate-Control or Rhythm-Control Strategy

23.05.20141735
Does left ventricular hypertrophy (LVH) affect outcomes in patients with atrial fibrillation (AF) managed with a rate-control or rhythm-control strategy?
123...6364656667...153154155
Enter the Society
Subscribe to Newsletter
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.